We are live on ! Find out more
RC

Roundview Capital Portfolio holdings

AUM $1.83B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+1.54%
1 Year Est. Return
+26.02%
3 Year Est. Return
+77.66%
5 Year Est. Return
+94.56%
10 Year Est. Return
+341.66%
AUM
$1.43B
AUM Growth
+$51.9M
Cap. Flow
+$44.3M
Cap. Flow %
3.09%
Top 10 Hldgs %
33.34%
Holding
348
New
10
Increased
187
Reduced
90
Closed
16

Top Buys

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$3.84M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$2.31M
3
BIV icon
Vanguard Intermediate-Term Bond ETF
BIV
+$2.29M
4
AMZN icon
Amazon
AMZN
+$2.11M
5
BAH icon
Booz Allen Hamilton
BAH
+$1.87M

Top Sells

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$1.65M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$1.29M
3
KLAC icon
KLA
KLAC
+$1.21M
4
CSGP icon
CoStar Group
CSGP
+$1,000K
5
KBH icon
KB Home
KBH
+$882K

Sector Composition

Rank Sector Weight
1 Technology 16.76%
2 Financials 14.29%
3 Industrials 7.36%
4 Consumer Discretionary 7.29%
5 Communication Services 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XAGE
326
DELISTED
Longevity Health Holdings, Inc. Common Stock
XAGE
$25.1K ﹤0.01%
3,000
-333
-10% -$3.16K
AFL icon
327
Aflac
AFL
$64.9B
– –
-1,869
Closed -$209K
CCI icon
328
Crown Castle
CCI
$33.3B
– –
-2,027
Closed -$240K
CNQ icon
329
Canadian Natural Resources
CNQ
$99.4B
– –
-14,748
Closed -$490K
CSGP icon
330
CoStar Group
CSGP
$11.7B
– –
-13,255
Closed -$1,000K
GMED icon
331
Globus Medical
GMED
$10.7B
– –
-7,833
Closed -$560K
IDXX icon
332
Idexx Laboratories
IDXX
$44.1B
– –
-3,265
Closed -$1.65M
INTC icon
333
Intel
INTC
$455B
– –
-8,986
Closed -$211K
KBH icon
334
KB Home
KBH
$3.37B
– –
-10,295
Closed -$882K
KLAC icon
335
KLA
KLAC
$239B
– –
-15,620
Closed -$1.21M
LYB icon
336
LyondellBasell Industries
LYB
$20B
– –
-2,594
Closed -$249K
OXY icon
337
Occidental Petroleum
OXY
$56.8B
– –
-10,220
Closed -$527K
TFX icon
338
Teleflex
TFX
$6.05B
– –
-906
Closed -$224K
VUSB icon
339
Vanguard Ultra-Short Bond ETF
VUSB
$8.94B
– –
-5,204
Closed -$260K
XBI icon
340
State Street SPDR S&P Biotech ETF
XBI
$9.95B
– –
-13,047
Closed -$1.29M
XLI icon
341
State Street Industrial Select Sector SPDR ETF
XLI
$32.8B
– –
-1,482
Closed -$201K
BSCO
342
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
– –
-40,839
Closed -$863K
10 11 12 13
14

Similar funds

SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return
RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return

Roundview Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Roundview Capital held 348 positions worth $1.43B, up 3.8% from $1.38B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Roundview Capital deployed $44.3M of net new capital in Q4 2024, opening 10 new positions and adding to 187 existing holdings. Its largest new stake was Invesco BulletShares 2028 Corporate Bond ETF: 45,661 shares worth $919K.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Diageo, an estimated $750K trimmed.

  • Roundview Capital's largest Q4 2024 buy was Invesco BulletShares 2028 Corporate Bond ETF: 45,661 shares worth $919K.
  • Roundview Capital added most to Vanguard Morningstar Total Stock Market ETF in Q4 2024, an estimated $3.84M increase.
  • Roundview Capital's biggest Q4 2024 reduction was Diageo, cutting an estimated $750K.
  • Roundview Capital fully exited Idexx Laboratories in Q4 2024, selling an estimated $1.65M.
  • Roundview Capital's ten largest holdings make up 33% of its $1.43B portfolio in Q4 2024.
  • Roundview Capital opened 10 new positions and closed 16 in Q4 2024.
  • Roundview Capital's portfolio value rose 3.8% quarter-over-quarter to $1.43B.

Based on Roundview Capital's 13F filing for Q4 2024, filed 12 Feb 2025.